BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22964749)

  • 1. High incidence of triple-negative tumors in sub-saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako university hospital.
    Ly M; Antoine M; Dembélé AK; Levy P; Rodenas A; Touré BA; Badiaga Y; Dembélé BK; Bagayogo DC; Diallo YL; Koné AA; Callard P; Bernaudin JF; Diallo DA
    Oncology; 2012; 83(5):257-63. PubMed ID: 22964749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years.
    Kawai M; Malone KE; Tang MT; Li CI
    Cancer; 2014 May; 120(10):1548-56. PubMed ID: 24500704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial comparison of receptor-defined breast cancer in Southern African women: subtype prevalence and age-incidence analysis of nationwide cancer registry data.
    Dickens C; Duarte R; Zietsman A; Cubasch H; Kellett P; Schüz J; Kielkowski D; McCormack V
    Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2311-21. PubMed ID: 25143359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DCE-MRI Pharmacokinetic-Based Phenotyping of Invasive Ductal Carcinoma: A Radiomic Study for Prediction of Histological Outcomes.
    Monti S; Aiello M; Incoronato M; Grimaldi AM; Moscarino M; Mirabelli P; Ferbo U; Cavaliere C; Salvatore M
    Contrast Media Mol Imaging; 2018; 2018():5076269. PubMed ID: 29581709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer in Patients with Previous Endometriosis Showed Low Aggressive Subtype.
    Vanni G; Selntigia A; Marsella VE; Russo C; Pellicciaro M; Materazzo M; Rizzo G; Buonomo OC; Exacoustos C
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674271
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of immunohistochemical tests in multimodal treatment of the aggressive forms of breast cancer.
    Mihai D; Voiculescu S; Dimitriu C; Constantinescu F; Stanilescu S; Burcos T
    J Med Life; 2014; 7 Spec No. 2(Spec Iss 2):58-64. PubMed ID: 25870675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to oncology care in Mali: a qualitative study on breast cancer.
    Schantz C; Coulibaly A; Traoré A; Traoré BA; Faye K; Robin J; Teixeira L; Ridde V;
    BMC Cancer; 2024 Jan; 24(1):81. PubMed ID: 38225594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological, Clinical, and Histopathological Features of Breast Cancer in Haiti.
    DeGennaro V; Jiwani F; Patberg E; Gibbs M; Libby R; Gabriel D; Heldermon CD; Daily K; Bernard J
    J Glob Oncol; 2018 Sep; 4():1-9. PubMed ID: 30241242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in Risk Factors for Breast Cancer by ER Status in an Indigenous African Population.
    Galukande M; Wabinga H; Mirembe F; Karamagi C; Asea A
    ISRN Oncol; 2013; 2013():463594. PubMed ID: 23936673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population.
    Galukande M; Wabinga H; Mirembe F; Karamagi C; Asea A
    Pan Afr Med J; 2014; 17():249. PubMed ID: 25309649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression Patterns of ER, PR, HER-2/neu and p53 in Association with Nottingham Tumour Grade in Breast Cancer Patients.
    Adedokun KA; Oluogun WA; Oyenike MA; Imodoye SO; Yunus LA; Lasisi SA; Bello IO; Kamorudeen RT; Adekola SA
    Sultan Qaboos Univ Med J; 2023 Nov; 23(4):526-533. PubMed ID: 38090235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer Phenotypes in Africa: A Scoping Review and Meta-Analysis.
    Onyia AF; Nana TA; Adewale EA; Adebesin AO; Adegboye BE; Paimo OK; De Campos OC; Bisi-Adeniyi TI; Rotimi OA; Oyelade JO; Rotimi SO
    JCO Glob Oncol; 2023 Sep; 9():e2300135. PubMed ID: 38085060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis.
    Mao X; Omeogu C; Karanth S; Joshi A; Meernik C; Wilson L; Clark A; Deveaux A; He C; Johnson T; Barton K; Kaplan S; Akinyemiju T
    BMC Cancer; 2023 Jul; 23(1):644. PubMed ID: 37430191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologically confirmed women's breast cancer: A descriptive study of Tunisian and Algerian series.
    Sassi F; Rekaya MB; Belarbi A; Chilla D; Mansouri N; Achouri L; Saied E; Kassa R; Kacem LB; Ouezani M; Debabeche N; Rebhi F; Rammeh S
    Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1818. PubMed ID: 37092543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neighborhood and racial influences on triple negative breast cancer: evidence from Northeast Ohio.
    Eom KY; Berg KA; Joseph NE; Runner K; Tarabichi Y; Khiyami A; Perzynski AT; Sossey-Alaoui K
    Breast Cancer Res Treat; 2023 Apr; 198(2):369-381. PubMed ID: 36781520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical Features of Breast Cancer Seen in Women in Kinshasa, Democratic Republic of the Congo: A Six-Year Retrospective Study.
    Maseb'a Mwang Sulu S; Batalansi DB; Sulu AMS; Mukuku O; Mboloko JE; Mashinda DK; Massamba BL; Tshimpi AW
    Int J Breast Cancer; 2022; 2022():8860947. PubMed ID: 35966938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early onset, delayed diagnosis and laterality of breast carcinoma: Evidence from a tertiary care hospital.
    Sume BW; Assefa W; Merkeb Alamneh Y
    SAGE Open Med; 2022; 10():20503121221114623. PubMed ID: 35910817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and Predictors of Mortality among Breast Cancer Patients in Northwest Ethiopia: A Retrospective Cohort Study.
    Tiruneh M; Tesfaw A; Tesfa D
    Cancer Manag Res; 2021; 13():9225-9234. PubMed ID: 34938122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of reproductive risk factors disclosed the heterogeneity of receptor-defined breast cancer subtypes among Tanzanian women.
    Rweyemamu LP; Akan G; Adolf IC; Magorosa EP; Mosha IJ; Dharsee N; Namkinga LA; Lyantagaye SL; Nateri AS; Atalar F
    BMC Womens Health; 2021 Dec; 21(1):423. PubMed ID: 34930226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Cancer Clinical Trials: The Landscape at the Uganda Cancer Institute and Lessons Learned.
    Menon MP; Niyonzima N; Gralow J; Orem J
    JCO Glob Oncol; 2021 Jan; 7():127-132. PubMed ID: 33449804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.